SCNI
Scinai Immunotherapeutics Ltd
NASDAQ: SCNI · HEALTHCARE · BIOTECHNOLOGY
$0.27
+1.02% today
Updated 2026-07-29
Market cap
$1.29M
P/E ratio
0.14
P/S ratio
1.06x
EPS (TTM)
$1.75
Dividend yield
—
52W range
$0 – $2
Volume
0.5M
Scinai Immunotherapeutics Ltd (SCNI) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.27
12-Month target
$0.75
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 0.14x (capped 25x) · Margin: -261.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.